In summary, our data suggest that Kras-driven NSCLC cells in the presence of Ezh2 inhibition and the transcription of inflammatory genes selectively rely on proteostasis and RNA synthesis to maintain cell fitness. Here, KRAS is linked to non-small cell lung carcinoma.